The recent surge in capital into boutique pharmaceutical companies, particularly those focusing on experimental therapies and difficult drug development programs, has fueled what some are calling "High Roller Pharma." https://umaircydw390390.blogspothub.com/38980139/premium-roller-pharma-hazardous-investment